0.74%| Prev Close: | 3.03 |
|---|---|
| Open: | 3.06 |
| Bid: | 3.01 |
| Ask: | 3.20 |
| 1y Target Est: | 3.25 |
| Beta: | 0.66 |
| Next Earnings Date: | N/A |
| Day's Range: | 3.06 - 3.10 |
|---|---|
| 52wk Range: | 1.74 - 3.72 |
| Volume: | 1,226 |
| Avg Vol (3m): | 4,379 |
| Market Cap: | 83.21M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | 0.06 (0.20%) |
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsCNW Group(Tue May 7)
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsPR Newswire(Tue May 7)
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsCNW Group(Tue May 7)
- Q3 2013 TRANSITION THERAPEUTICS INC Earnings Release - After Market CloseCCBN(Tue May 7)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTCNW Group(Mon May 6)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTPR Newswire(Mon May 6)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTCNW Group(Mon May 6)
- Transition Therapeutics Still Undervalued: Good Trial Outcome Shifts Focus To Lilly Decisionat Seeking Alpha(Tue Apr 30)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401CNW Group(Tue Apr 30)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401PR Newswire(Tue Apr 30)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401CNW Group(Tue Apr 30)
- Transition Therapeutics Announces Second Quarter Fiscal 2013 Financial ResultsCNW Group(Thu Feb 7)
- Transition Therapeutics Announces Second Quarter Fiscal 2013 Financial ResultsPR Newswire(Thu Feb 7)
- Transition Therapeutics Announces Second Quarter Fiscal 2013 Financial ResultsCNW Group(Thu Feb 7)
- Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2013 Financial Results on Thursday, February 7th, at 4:30 P.M. ESTCNW Group(Mon Feb 4)
Press Releases
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsCNW Group(Tue May 7)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTCNW Group(Mon May 6)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401CNW Group(Tue Apr 30)
Must Read
- Oil falls below $94 on weak economic outlook, lukewarm demandThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Sears reports bigger-than-expected loss for 1st quarterThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Gap's 1st-quarter net income rises 43 per cent on strong sales as turnaround continuesThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Ralph Lauren's 4Q profit rises 35 pct, but posts sales shortfallThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Marathon Oil: talks tied to sale of part of stake in Athabasca Oil Project have endedThe Canadian Press(1969-12-31T18:59:59GMT-05:00)